Marianne Farnebo
Solna, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides.
Journal: Nature communications
Published: December 15, 2025
Control of protein synthesis through mRNA pseudouridylation by dyskerin.
Journal: Science advances
Published: July 28, 2023
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.
Journal: Molecular oncology
Published: November 08, 2022
Evaluation of dyskerin expression and the Cajal body protein WRAP53β as potential prognostic markers for patients with primary vaginal carcinoma.
Journal: Oncology letters
Published: April 01, 2021
Small Cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK.
Journal: Nature communications
Published: April 01, 2021
Rise of the neglected repeats RNA.
Journal: Nature reviews. Molecular cell biology
Published: December 18, 2019
Biallelic mutations in WRAP53 result in dysfunctional telomeres, Cajal bodies and DNA repair, thereby causing Hoyeraal-Hreidarsson syndrome.
Journal: Cell death & disease
Published: November 14, 2019
The Cajal Body Protein WRAP53β Prepares the Scene for Repair of DNA Double-Strand Breaks by Regulating Local Ubiquitination.
Journal: Frontiers in molecular biosciences
Published: May 10, 2019
Neutralization of the Positive Charges on Histone Tails by RNA Promotes an Open Chromatin Structure.
Neutralization of the Positive Charges on Histone Tails by RNA Promotes an Open Chromatin Structure.
Journal: Cell chemical biology
Published: April 24, 2019
RNF8 - The Achilles heel of DNA repair when splicing rules.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 12, 2018
WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
Journal: Oncology reports
Published: February 27, 2017
Last Updated: 09/26/2026